Thymol targeting interleukin 4 induced 1 expression reshapes the immune microenvironment to sensitize the immunotherapy in lung adenocarcinoma

Immune checkpoint blockades are the most promising therapy in lung adenocarcinoma (LUAD). However, the response rate remains limited, underscoring the urgent need for effective sensitizers. Interleukin 4 induced 1 (IL4I1) is reported to have immunoinhibitory and tumor‐promoting effects in several ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tong, Shi, Jie, Wang, Longlong, Qin, Xuan, Zhou, Rui, Dong, Ming, Ren, Fan, Li, Xin, Zhang, Zihe, Chen, Yanan, Liu, Yanhua, Piao, Yongjun, Shi, Yi, Xu, Song, Chen, Jun, Li, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466095/
https://www.ncbi.nlm.nih.gov/pubmed/37655051
http://dx.doi.org/10.1002/mco2.355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466095/
https://www.ncbi.nlm.nih.gov/pubmed/37655051
http://dx.doi.org/10.1002/mco2.355

Ejemplares similares